To expedite invasive management for acute coronary syndrome, which action is indicated?

To expedite invasive management for acute coronary syndrome, which action is indicated?

• A. Placement of Defib Pads
• B. Continuous Cardiac Monitoring
• C. Prepare to Transport to Cardiac Cath Lab
• D. Administer a third dose of nitroglycerin

Answer: (C)

In acute coronary syndrome, getting definitive reperfusion as quickly as possible is the priority. The quickest way to expedite invasive management is to prepare to transport the patient to the cardiac catheterization lab and activate the interventional team now. This means notifying the cath lab, coordinating with the interventional cardiology team, and getting the patient ready for PCI so they can be moved promptly when a bed and team are available. The goal is to minimize time from first medical contact to reperfusion (door-to-balloon time), which improves outcomes. Defibrillator pads and continuous cardiac monitoring are essential for safety during stabilization, but they don’t directly speed up invasive treatment. Giving nitroglycerin can relieve symptoms in some patients, but a third dose without considering hemodynamics may delay definitive care and isn’t aimed at expediting the procedure.

In acute coronary syndrome, getting definitive reperfusion as quickly as possible is the priority. The quickest way to expedite invasive management is to prepare to transport the patient to the cardiac catheterization lab and activate the interventional team now. This means notifying the cath lab, coordinating with the interventional cardiology team, and getting the patient ready for PCI so they can be moved promptly when a bed and team are available. The goal is to minimize time from first medical contact to reperfusion (door-to-balloon time), which improves outcomes.

Defibrillator pads and continuous cardiac monitoring are essential for safety during stabilization, but they don’t directly speed up invasive treatment. Giving nitroglycerin can relieve symptoms in some patients, but a third dose without considering hemodynamics may delay definitive care and isn’t aimed at expediting the procedure.